Successful Treatment of Dermatomyositis During Pregnancy With Intravenous Immunoglobulin Monotherapy

Abstract

Pregnant patients with dermatomyositis can be treated with intravenous immune globulin, resulting in good fetal outcome, thus avoiding the deleterious effects of corticosteroid therapy on pregnancy.